“…Hence, the results are not standardized. 11 , 12 , 13 , 14 , 15 , 16 We believe that the use of an immunohistochemical panel including Ber‐EP4, CD34 and Bcl2 and AR, could be useful in the differential diagnosis of adnexal neoplasms, BCC and mimickers, especially in small biopsies where the evaluation of all histological criteria could be limited. 17 In particular, our study proved that the two antibodies with notable differences between BFH and BCC were Bcl2 and CD34.…”